412 related articles for article (PubMed ID: 8955053)
21. The development of persistent duck hepatitis B virus infection can be prevented using antiviral therapy combined with DNA or recombinant fowlpoxvirus vaccines.
Feng F; Teoh CQ; Qiao Q; Boyle D; Jilbert AR
Vaccine; 2010 Oct; 28(46):7436-43. PubMed ID: 20833122
[TBL] [Abstract][Full Text] [Related]
22. [Inhibitory effect of trisodium phosphonoformate (PFA) on duck hepatitis B virus (DHBV) DNA in vivo].
Chen X; Chen H
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1997 Sep; 11(3):277-81. PubMed ID: 15617348
[TBL] [Abstract][Full Text] [Related]
23. The effect of surgical immunomodulation on liver inflammation and clearance of DHBV infection.
Vickery K; Tohidi-Esfahani R; Pouliopoulos J; Welschinger R; Dixon R; Deva A; Cossart Y
J Med Virol; 2006 Dec; 78(12):1572-8. PubMed ID: 17063509
[TBL] [Abstract][Full Text] [Related]
24. Effects of liver growth factors on hepadnavirus replication in chronically infected duck hepatocytes.
Schorr O; Borel C; Trepo C; Zoulim F; Hantz O
J Hepatol; 2006 May; 44(5):842-7. PubMed ID: 16458387
[TBL] [Abstract][Full Text] [Related]
25. Enhanced duck hepatitis B virus gene expression following aflatoxin B1 exposure.
Barraud L; Guerret S; Chevallier M; Borel C; Jamard C; Trepo C; Wild CP; Cova L
Hepatology; 1999 Apr; 29(4):1317-23. PubMed ID: 10094981
[TBL] [Abstract][Full Text] [Related]
26. Cellular immune response of ducks to duck hepatitis B virus infection.
Vickery K; Cossart Y; Dixon R
J Med Virol; 1999 May; 58(1):19-25. PubMed ID: 10223541
[TBL] [Abstract][Full Text] [Related]
27. Effect of antiviral treatment with entecavir on age- and dose-related outcomes of duck hepatitis B virus infection.
Foster WK; Miller DS; Scougall CA; Kotlarski I; Colonno RJ; Jilbert AR
J Virol; 2005 May; 79(9):5819-32. PubMed ID: 15827196
[TBL] [Abstract][Full Text] [Related]
28. Characterization of the antiviral effects of 2' carbodeoxyguanosine in ducks chronically infected with duck hepatitis B virus.
Mason WS; Cullen J; Saputelli J; Wu TT; Liu C; London WT; Lustbader E; Schaffer P; O'Connell AP; Fourel I
Hepatology; 1994 Feb; 19(2):398-411. PubMed ID: 8294097
[TBL] [Abstract][Full Text] [Related]
29. Geographical pathology of duck livers infected with duck hepatitis B virus from Chiba and Shimane in Japan and Shanghai in China.
Uchida T; Suzuki K; Arii M; Shikata T; Fukuda R; Tao YX
Cancer Res; 1988 Mar; 48(5):1319-25. PubMed ID: 3342410
[TBL] [Abstract][Full Text] [Related]
30. The role of duck hepatitis B virus and aflatoxin B1 in the induction of oxidative stress in the liver.
Barraud L; Douki T; Guerret S; Chevallier M; Jamard C; Trepo C; Wild CP; Cadet J; Cova L
Cancer Detect Prev; 2001; 25(2):192-201. PubMed ID: 11341355
[TBL] [Abstract][Full Text] [Related]
31. Characterisation of the Indian strain of duck hepatitis B virus (DHBV) and development of a carrier duck colony for antiviral drug testing.
Munshi A; Mehrotra R; Panda SK
Trop Gastroenterol; 1994; 15(2):77-85. PubMed ID: 7831721
[TBL] [Abstract][Full Text] [Related]
32. [Comparison of specific immune responses to duck hepatitis B virus in infected, immune, and uninfected ducks].
Tang N; Huang A; Guo S; Qi Z; Zhang D
Zhonghua Gan Zang Bing Za Zhi; 2001 Jun; 9(3):166-8. PubMed ID: 11412394
[TBL] [Abstract][Full Text] [Related]
33. Rapid resolution of duck hepatitis B virus infections occurs after massive hepatocellular involvement.
Jilbert AR; Wu TT; England JM; Hall PM; Carp NZ; O'Connell AP; Mason WS
J Virol; 1992 Mar; 66(3):1377-88. PubMed ID: 1738197
[TBL] [Abstract][Full Text] [Related]
34. [Antisense oligodeoxynucleotide targeted at the pre-s region of DHBV could inhibit virus replication in vivo].
He L; Wu X; Chen C
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1998 Mar; 12(1):1-4. PubMed ID: 12515159
[TBL] [Abstract][Full Text] [Related]
35. [Ultrastructural study and localization of duck hepatitis B virus in the livers of experimentally infected ducks].
Tian P
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1991 Apr; 13(2):108-11. PubMed ID: 1831706
[TBL] [Abstract][Full Text] [Related]
36. Demonstration of duck hepatitis B virus in bile duct epithelial cells: implications for pathogenesis and persistent infection.
Nicoll AJ; Angus PW; Chou ST; Luscombe CA; Smallwood RA; Locarnini SA
Hepatology; 1997 Feb; 25(2):463-9. PubMed ID: 9021965
[TBL] [Abstract][Full Text] [Related]
37. Experimental study on pathogenicity of precore mutants in Hepadnaviridae.
Ma Z; Wen Y; Xiong S; Zhai W; He L; Yao X
Chin Med J (Engl); 1998 Jun; 111(6):519-23. PubMed ID: 11245071
[TBL] [Abstract][Full Text] [Related]
38. DHBV manipulation and prediction of the outcome of infection.
Vickery K; Cossart Y
J Hepatol; 1996 Oct; 25(4):504-9. PubMed ID: 8912150
[TBL] [Abstract][Full Text] [Related]
39. Influence of aflatoxin B1 intoxication on duck livers with duck hepatitis B virus infection.
Uchida T; Suzuki K; Esumi M; Arii M; Shikata T
Cancer Res; 1988 Mar; 48(6):1559-65. PubMed ID: 3125965
[TBL] [Abstract][Full Text] [Related]
40. Comparison of the kinetics of the specific cellular immune response to duck hepatitis B virus in infected and immune ducks.
Vickery K; Cossart Y; Dixon R
Vet Microbiol; 1999 Aug; 68(1-2):157-69. PubMed ID: 10501173
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
